Transperineal interstitial permanent prostate brachytherapy for carcinoma of the prostate

Surgical Oncology

Volumn 11, Issue 1-2, 2002, Pages 25-34

  Pedley, Ian David ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Brachytherapy; Prostate cancer; Review; Treatment

Indexed keywords

IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BRACHYTHERAPY; DOSIMETRY; ERECTILE DYSFUNCTION; FOLLOW UP; HEMATOMA; HEMATURIA; HEMOSPERMIA; HUMAN; IMPLANTATION; MONOTHERAPY; PATIENT SELECTION; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; PROSTATE CARCINOMA; RADIATION DOSE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; ULTRASOUND; URINARY TRACT INFECTION; URINE INCONTINENCE;

BRACHYTHERAPY; CARCINOMA; HUMANS; IODINE RADIOISOTOPES; MALE; PALLADIUM; PATIENT SELECTION; PERINEUM; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 0036274346     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(02)00010-5     Document Type: Article

References (53)

1. The radium treatment of cancer of the prostate
2. Radium in treatment of bladder and prostate
3. Retropubic implantation of Iodine-125 in the treatment of prostate cancer
4. Iodine implantation for carcinoma of the prostate: 5-year survival free of disease and incidence of local failure
5. Transperineal iodine seed implantation in prostatic cancer guided by transrectal ultasonography
6. Transperineal ultrasound-guided implantation of the prostate: Morbidity and complications
7. American Brachytherapy Society (ABS) Recommendations for Transperineal Permanent Brachytherapy of Prostate Cancer
8. A survey of current clinical practice of permanent prostate brachytherapy in the United States
9. Dosimetry of interstitial brachytherapy sources; Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 and the Radiation Therapy Committee Task Group No. 43
10. Timing of computed tomography-based post implant assessment following permanent transperineal prostate brachytherapy
11. A review of post implant quality assessment in permanent transperineal interstitial prostate brachytherapy
12. CT-based evaluation method for permanent implants: Application to prostate
13. Centralised multi-institutional post implant analysis for interstitial prostate brachytherapy
14. ESTRO/EAU/EORTC recommendations of permanent seed implantation for localised prostate cancer
15. A dose response study for I 125 prostate implants
16. Consensus statement: Guidelines for PSA following radiation therapy: American Society for Therapeutic Radiation Oncology Consensus panel
17. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer
18. Salvage surgery or salvage radiotherapy for locally recurrent prostate cancer
19. Androgen depravation with salvage surgery for radio-recurrent prostate cancer results at 5 year follow-up
20. Prostate specific antigen in the preoperative and postoperative evaluation of localised prostatic cancer treated with radical prostatectomy
21. Prostate specific antigen based disease control following ultrasound guided I 125 implantation for Stage T1/T2 prostatic carcinoma
22. Prostate specific antigen monitored combination radiotherapy for patients with prostate cancer; I 125 implant followed by external beam radiation
23. Relationship between perineural tumour invasion or needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate
24. Predicted value of controlateral biopsies in unilaterally palpable prostate cancer
25. Tumour control of morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma
26. Urinary morbidity following ultrasound guided transperineal prostate seed implantation
27. Ten year biochemical (prostate specific antigen) control of prostate cancer with I-125 brachytherapy
28. Brachytherapy for clinically localised prostate cancer
29. Palladium 103 brachytherapy for prostate carcinoma
30. Brachytherapy in the management of prostate cancer
31. Ten year disease free survival after transperineal sonography guided Iodine-125 brachytherapy with or without 45Gy external irradiation in the treatment of patients with clinically localised low to high Gleason grade prostate carcinoma
32. Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with by plain ultrasound and fluoroscopic guidance
33. Transperineal ultrasound guided I-125/Pd 103 brachytherapy for early stage prostate cancer. Update on clinical experience at seven years
34. Shipley WU neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: Experimental and clinical results
35. Phase 3 trial of androgen suppression using goserelin in unfavourable prognosis carcinoma of prostate, treated by definitive radiotherapy (report of RTOG protocol 85-31)
36. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
37. Prostatectomy versus brachytherapy for early stage prostate cancer
38. Radiotherapy options for localised prostate cancer based on pre treatment serum prostate specific antigen levels and a biochemical control: A comprehensive review of the literature
39. Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for localised prostate cancer
40. The influence of prophylatic dexamethasone on edema following prostate brachytherapy
41. Temporal resolution of urinary morbidity following prostate brachytherapy
42. Transrectal ultrasound guided interstitial radiation therapy for localised prostate cancer
43. Identification of patients at increased risk from prolonged urinary retention following radioactive seed implantation of the prostate
44. Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy
45. Rectal and urinary morbidity in patients undergoing prostate 125 implant (abstr)
46. Biochemical disease free survival following I-125 prostate implantation
47. Clinical course of rectal bleeding following I-125 prostate brachytherapy
48. The role of external beam radiotherapy with I-125/Pd 103 brachytherapy for prostate carcinoma
49. Potency after transperineal prostate brachytherapy for localised prostate cancer
50. Brachytherapy and organ preservation in the management of carcinoma of the prostate
51. Erectile dysfunction following radical therapy for prostate cancer
52. Salvage brachytherapy for localised prostate cancer after radiotherapy failure